Case File
efta-efta00707071DOJ Data Set 9OtherFrom: "Fenn, Patrick" <a
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00707071
Pages
3
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Fenn, Patrick" <a
To: Jeffrey Epstein <[email protected]>
Subject: Re: AMH refinancing - discussion materials
Date: Tue, 19 Nov 2013 13:54:56 +0000
3 works. Thanks
From: Jeffrey Epstein
Sent: Tuesday, November 19, 2013 8:09 AM
To: Fenn, Patrick
Subject: Re: AMH refinancing - discussion materials
early afternon? 2 ,3 ?
On Tue, Nov 19, 2013 at 1:27 AM, Fenn, Patrick <
<mailto:I=1=1.=>>
wrote:
Great. Thanks. Will call you late morning.
From: [email protected]:jeevacation®gmail.com>
Sent: Monday, November 18, 2013 7:25 PM
To: Fenn, Patrick
Subject: Re: AMH refinancing - discussion materials
Tomorw
Sony for all the typos .Sent from my iPhone
On Nov 18 2013, at 6:24 PM, "Fenn, Patrick"
mailto
mailto:a>>>
wrote:
Hi Jeffrey. Do you have a minute to discuss the basic refi proposal (without the personal guarantee question)
later this afternoon? Thanks
From: Fenn, Patrick
Sent: Friday, November 15, 2013 6:45 AM
To: 1jeevacation®gmail.conailto:[email protected]>
<[email protected]@gmail.com>>1
Subject: FW: AMH refinancing - discussion materials
Hi Jeffrey. Hope all is well.
EFTA00707071
AMH is the process of refinancing its existing bank loan facility. The attached materials include a summary of
the refinancing terms, and the provision of a revolving loan facility, as presented to JPMorgan. The attachment
also includes a page addressing the tax and structural aspects of the new facilities, which was prepared for the
benefit of the company. In that regard, it is not anticipated that the mere refinancing of the existing loan under
the terms proposed, including the extension of the collateral for the facilities to include the carried interest
vehicles, would have any adverse income tax consequences for the Founders either currently or at the time of an
exchange.
You will note that the refinancing terms refer to the potential for personal guarantees of the refinanced term debt
by the Founders (but not the new revolver). Earlier this year, we discussed at great length the net tax effects to
the Founders of guaranteeing the debt, essentially deferral of tax on what we referred to as the "Tufts gain" -- the
gain that a Founder recognizes on an exchange of AOG Units for AGM Class A Shares as a result of his current
negative capital account in AMH, offset by the impact of the deferral of such gain on the timing and (potentially)
amount of the TRA payments. While there was an overall economic benefit based on modeling we did at the
time, you may recall from that prior discussion that the opportunity for maximum benefit depends upon the
Founders acting in concert (and pro rata) with respect to the personal guarantees.
In order to assist you with a re-evaluation of this deferral opportunity for Leon, I will send around next week an
outline of the potential tax effects of the personal guarantees and, to the extent helpful, will arrange to speak with
you later next week. While it is not essential that the decision to provide personal guarantees be made before the
closing of the refinancing (timelined for the week of December 9th), my preference would be to try to get
consensus on the subject before such time.
In the meantime, please let me know Jeffrey if you have any questions concerning the attached. Also let me
know if you want me to copy in any other advisors on this review.
Best regards
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered opinion, within
the meaning of Circular 230 issued by the United States Secretary of the Treasury. Thus, we are required to
inform you that you cannot rely upon any tax advice contained in this communication for the purpose of
avoiding United States federal tax penalties. In addition, any tax advice contained in this communication may
not be used to promote, market or recommend a transaction to another party.
The information contained in this e-mail message is intended only for the personal and confidential use of the
recipient(s) named above. If you have received this communication in error, please notify us immediately by e-
mail, and delete the original message.
<AGM_AMH loan considerations_11 13 13 vRevised.pdf>
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered opinion, within
the meaning of Circular 230 issued by the United States Secretary of the Treasury. Thus, we are required to
inform you that you cannot rely upon any tax advice contained in this communication for the purpose of
avoiding United States federal tax penalties. In addition, any tax advice contained in this communication may
not be used to promote, market or recommend a transaction to another party.
The information contained in this e-mail message is intended only for the personal and confidential use of the
recipient(s) named above. If you have received this communication in error, please notify us immediately by e-
mail, and delete the original message.
EFTA00707072
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com<mailto:jeevacation®gmail.com>, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered
opinion, within the meaning of Circular 230 issued by the United States Secretary of the Treasury.
Thus, we are required to inform you that you cannot rely upon any tax advice contained in this
communication for the purpose of avoiding United States federal tax penalties. In addition, any tax
advice contained in this communication may not be used to promote, market or recommend a transaction
to another party.
The information contained in this e-mail message is intended only for the personal and confidential
use of the recipient(s) named above. If you have received this communication in error, please notify
us immediately by e-mail, and delete the original message.
EFTA00707073
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Wire Ref
refinancedWire Ref
refinancingRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.